COVAXIN to boost immune response, longer-lasting immunity with ViroVax’s adjuvant EP News Bureau Oct 5, 2020 Bharat Biotech has announced its novel coronavirus vaccine COVAXIN approved for human trials, will use adjuvant Alhydroxiquim-II…
